spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  epidermolysis bullosa 

 HSMN NewsFeed - 21 Oct 2020
FDA Grants Fast Track Status to Aegle Therapeutics' AGLE-102 for the Treatment of Dystrophic Epidermolysis Bullosa
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 29 Sep 2020
Aegle Therapeutics Completes $6.5M Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 Jun 2019
Castle Creek Pharmaceuticals Appoints Mary Spellman, M.D., as Chief Medical Officer and Senior Vice President of Research & Development
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 21 Mar 2019
RegeneRx Announces New Board Member
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2018
RegeneRx Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 2 Apr 2018
Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Aug 2017
RegeneRx Completes License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 19 Dec 2016
Fibrocell Announces Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2016
Novelion Therapeutics Subsidiary, Aegerion Pharmaceuticals, Enters Into Licensing Agreement With Amryt Pharma for LOJUXTA(R) (lomitapide)
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 6 Jul 2016
Knight and Ember Expand Distribution Partnership
Biopharmaceuticals Distribution
 HSMN NewsFeed - 16 Mar 2016
Ember Therapeutics Enhances Regenerative Medicine Pipeline With Acquisition of ICX-RHY/Vavelta(TM) from Intercytex
Regenerative Medicine Dermatology Acquisitions
 HSMN NewsFeed - 2 Oct 2015
Amicus Therapeutics Provides U.S. Regulatory Update for Migalastat Monotherapy
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Dec 2014
Scioderm, Inc. Closes $20 Million Series B Round of Financing
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 24 Nov 2014
Agilis Biotherapeutics Names Former Shire Executive Dr. Gregory Robinson as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jun 2014
Scioderm Names Ronald Nardi, Ph.D. Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Feb 2012
Researchers Show TB4 Provides Both Neuroprotection and Neurorestoration after Traumatic Brain Injury
Biopharmaceuticals Neurology Regenerative Medicine
 HSMN NewsFeed - 9 Jan 2008
Ortec Shareholders Approve Corporate Name Change to Forticell Bioscience, Inc.
Regenerative Medicine Wound Care
 HSMN NewsFeed - 11 Sep 2007
RegeneRx Receives U.S. Patent for Wound Healing Technology
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 31 Jul 2007
RegeneRx Biopharmaceuticals, Inc. Updates Clinical Trials Program
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 11 Jul 2007
Ortec International: Dr. Costa Papastephanou Appointed CEO
Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 26 Feb 2007
Ortec Initiates Premarket Approval (PMA) Application Filing Seeking Approval for OrCel(R) in Treating Venous Leg Ulcers
Regenerative Medicine Wound Care FDA
 HSMN NewsFeed - 29 Sep 2006
FDA Issues Approvable Letter to Ortec for Use of Cryopreserved OrCel(R) in Epidermolysis Bullosa Patients' Hand Reconstructions and Donor Sites
Regenerative Medicine FDA
 HSMN NewsFeed - 12 Sep 2006
Ortec Announces Positive Results in Confirmatory Venous Leg Ulcer Trial
Devices Wound Care Regenerative Medicine
 HSMN NewsFeed - 3 Aug 2006
Ortec's FDA Approved Cell Line Plays Pivotal Role in Creation of First Embryonic Stem Cell Lines Fit for Human Clinical Trials
Regenerative Medicine
 HSMN NewsFeed - 17 Jul 2006
Cambrex and Ortec Submit to FDA a Humanitarian Device Exemption (HDE) for OrCel(R) to Treat Epidermolysis Bullosa Patients
Devices
 HSMN NewsFeed - 6 Jul 2006
Ortec Issues Update on Its Three Technology Platforms for Regenerative Medicine and Stem Cells
Regenerative Medicine
 HSMN NewsFeed - 25 Apr 2006
Ortec Completes Patient Enrollment for Confirmatory Trial Evaluating OrCel(R) in Healing Venous Leg Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 27 Jan 2006
PTC Therapeutics Initiates Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy
Biopharmaceuticals Neurology
Return to NewsFeed  

 Additional items found! 18

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 18 additional stories matching:
epidermolysis bullosa
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.